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Amyloid proteins are involved in many neurodegenerative disorders such as Alzheimer’s
disease [Tau, Amyloid β (Aβ)], Parkinson’s disease [alpha-synuclein (αSyn)], and
amyotrophic lateral sclerosis (TDP-43). Driven by the early observation of the presence
of ordered structure within amyloid fibrils and the potential to develop inhibitors of their
formation, a major goal of the amyloid field has been to elucidate the structure of the
amyloid fold at atomic resolution. This has now been achieved for a wide variety of
sequences using solid-state NMR, microcrystallography, X-ray fiber diffraction and cryo-
electron microscopy. These studies, together with in silico methods able to predict
aggregation-prone regions (APRs) in protein sequences, have provided a wealth of
information about the ordered fibril cores that comprise the amyloid fold. Structural and
kinetic analyses have also shown that amyloidogenic proteins often contain less well-
ordered sequences outside of the amyloid core (termed here as flanking regions) that
modulate function, toxicity and/or aggregation rates. These flanking regions, which often
form a dynamically disordered “fuzzy coat” around the fibril core, have been shown to
play key parts in the physiological roles of functional amyloids, including the binding of
RNA and in phase separation. They are also the mediators of chaperone binding and
membrane binding/disruption in toxic amyloid assemblies. Here, we review the role of
flanking regions in different proteins spanning both functional amyloid and amyloid in
disease, in the context of their role in aggregation, toxicity and cellular (dys)function.
Understanding the properties of these regions could provide new opportunities to target
disease-related aggregation without disturbing critical biological functions.
Keywords: flanking region, amyloid, synuclein, fuzzy coat, aggregation, Tau, TDP-43, Orb2
INTRODUCTION
In the 60 years since the first atomic structure of the protein myoglobin was solved using X-ray
diffraction of protein crystals (Kendrew et al., 1960), the field of structural biology has been
dominated by the study of globular proteins with a well-defined tertiary structure, with more than
160,000 unique structures solved to date using crystallography, NMR or cryoEM (Geraets et al.,
2020). Despite this feat, more than 50% of the proteins in eukaryotes are now known to have at least
one long (>30 residues) sequence that is intrinsically disordered [intrinsically disordered regions
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(IDRs)] and also 12% of eukaryotic proteins are completely
intrinsically disordered [intrinsically disordered proteins (IDPs)]
(Dunker et al., 2000; Ward et al., 2004; Tompa, 2009). IDRs and
IDPs are enriched in/for proteins with important regulatory or
signaling functions (Ward et al., 2004; Tompa et al., 2006; Coletta
et al., 2010) demonstrating the crucial role of non-globular
protein structures for biological processes.
Amyloid proteins, some of which are involved in
neurodegenerative disorders such as Alzheimer’s disease,
Parkinson’s disease, amyotrophic lateral sclerosis, and
Huntington disease (Iadanza et al., 2018a; Benson et al.,
in press) are commonly IDPs or are proteins that contain
IDRs. These diseases share a common fundamental etiology:
aberrant self-assembly of their amyloid precursor proteins
to form toxic oligomers and highly ordered fibrils with a
cross β-sheet structure (Gallardo et al., 2020b; Ulamec and
Radford, 2020). A combination of biochemical and biophysical
approaches, including limited proteolysis, hydrogen exchange
(HX), solution NMR, solid state NMR (ssNMR), cryoEM and
EPR have shown that the structured cross-β amyloid core
commonly involves only a portion of the amyloid precursor
sequence, whilst regions flanking the fibril core (commonly
the N- and/or C-terminal regions of the sequence), are flexible
and thus are either “invisible” in the structures determined or
give rise to only low resolution density in EM images (Gallardo
et al., 2020b). Consequently, the high resolution cryoEM and
ssNMR structures of fibril architectures determined over the
last ∼5 years, have necessarily focused on the conformations
and interactions within fibril cores (Gallardo et al., 2020b),
whilst the more dynamic flanking regions remain elusive. The
structured cores of amyloid fibrils usually contain short peptide
sequences, some with high aggregation propensity, shown to
be necessary and sufficient for fibril formation (Giasson et al.,
2001; Thompson et al., 2006) and reviewed in Eisenberg and
Sawaya (2017). Despite the importance of these sequences for
the formation and stability of the amyloid fold, several studies
have shown that modifying or changing (e.g., by deletion,
mutation, or post-translational modification) the regions that
flank the amyloid core can affect the fibril growth kinetics
(Johnson et al., 2009; Benilova et al., 2014; Doherty et al., 2020),
fibril morphology (Guerrero-Ferreira et al., 2020; Scheres et al.,
2020) and the formation of crucial contacts with interaction
partners (Gao et al., 2015; Burmann et al., 2020; Figure 1).
Additionally, the presence of so called “gatekeeper” residues,
which surround aggregation-prone regions (APRs) to mitigate
their aggregation propensity (Reumers et al., 2009) further
underlines the important role of residues not directly involved
in forming the amyloid core in the process of aggregation and
in the functional consequences of the fibril structure formed.
The aim of this review is to highlight the importance of the
dynamically disordered flanking regions in amyloid sequences,
focusing on their roles in fibril formation, cytotoxicity, and other
physiological functions. While more than 50 proteins are known
to form amyloid associated with disease (Iadanza et al., 2018a;
Benson et al., in press), here we focus on αSyn, TDP-43, Aβ,
Tau, β2m, Orb2, and PrP as exemplars of IDPs, natively folded
proteins, prions, and functional and disease related proteins.
FLANKING REGIONS – WHAT ARE THEY
AND WHY ARE THEY IMPORTANT?
Decades of studies of protein folding have led to insights into
the roles of individual amino acids in a protein sequence in the
search for the native fold (they are kinetically important) and
in stabilizing the final folded state (they are thermodynamically
important) (Rumbley et al., 2001; Baldwin et al., 2011). In
addition, some residues may be conserved because they are
important in chaperone binding or in the destabilization of
incorrect folds (so-called negative design) (Richardson and
Richardson, 2002; Berezovsky et al., 2007). By contrast with
our the wealth of knowledge about protein folding, predicting
which residues in an amyloid precursor sequence could be
kinetically important in driving or controlling the rate or
mechanism of amyloid fibril formation; which form the stable
fibril core; and which may be innocuous passengers during
self-assembly, but may play a role in the fibrillar state, is
immensely complex. This is a fundamentally important question,
since it is now widely appreciated that, by contrast with
protein folding wherein the same globular structure is (usually)
adopted by a protein sequence independent of mutation or
changes in the solution conditions, amyloid fibril formation
is under kinetic control, with the structure of the fibril
product being determined by the assembly pathway taken
(Figure 1). The result is a rugged energy landscape, which
can result in potentially many different fibril structures for
the same (or very similar) protein sequences (known as fibril
polymorphism) (Fitzpatrick et al., 2017; Close et al., 2018;
Kollmer et al., 2019; Guerrero-Ferreira et al., 2020). Recent
advances in computational methods have provided a suite of
algorithms able to define the most aggregation prone region of
a protein sequence (Fernandez-Escamilla et al., 2004; Sormanni
et al., 2015; Ebo et al., 2020; Figure 2A). These regions are
commonly found in the amyloid fibril core, stabilizing the
final fibril structure, without necessarily playing a role in the
kinetics of amyloid formation. Other residues in amyloidogenic
peptides and proteins which flank the APRs, can play kinetic
and/or thermodynamic roles in amyloid assembly. Changes in
these sequences (mutation or post-translational modification)
can dramatically alter the rates of fibril formation and the
structures of the fibrils formed, without the sequence necessarily
forming part of the stable fibril core. As more fibril structures
are solved of full-length protein sequences (rather than short
peptide fragments), it is becoming clear that the amyloid
core can involve only a minor part of the protein sequence,
with substantial regions of the polypeptide chain remaining
dynamically disordered in the fibril structure (Figure 2A).
Such regions which flank the amyloid core can play functional
roles (binding ligands and receptors for functional amyloid),
or perturbing proteostasis (for amyloid fibrils associated with
disease) (Figures 2B–D).
In this review we focus on the roles of regions that flank the
APRs and/or fibril cores in amyloid formation. We differentiate
between (i) sequences that flank the APRs determined by in silico
techniques, (ii) sequences that flank the structured cross-β fibril
core based on recent cryoEM and NMR structures of fibrils,
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FIGURE 1 | Schematic energy landscape of folding and aggregation of
proteins focusing on factors affecting the kinetics of folding and amyloid
assembly. The surface shows the conformations that proteins can adopt
(monomeric and aggregated species) during folding and aggregation into
amyloid. The lowest energy state is the amyloid fibril (Baldwin et al., 2011).
Adopting a folded native structure or stabilization of this structure by ligand
binding, disfavors amyloid formation, whilst mutations or post-translational
modifications that favor inter-molecular interactions and phase separation can
destabilize the monomer and tip the balance toward fibril formation. Binding of
a protein to a membrane surface can also favor aggregation, by changing the
structure of the amyloid precursor and driving inter-molecular interactions.
Note that the relative position of each folding- and aggregation-factor within
the energy landscape is arbitrary, as these factors can influence folding and
aggregation at multiple different points. Their relative position, therefore, does
not imply that they act at only one point on the landscape, or interact with a
specific folding or aggregation intermediate.
and (iii) sequences that flank coincident APRs and fibril cores
(producing an “aggregation hotspot”) (Figure 2). In 2005 used
a similar approach where they differentiated between regions
that are predicted to be most important for promoting amyloid
growth and experimentally determined sensitive regions Dobson
and coworkers (Pawar et al., 2005). It is important to note
that different flanking regions can be identified in the same
protein using these definitions. For example, the use of different
algorithms [e.g., CamSol or TANGO (Figure 3)] as well as
posttranslational modifications, might result in different flanking
regions for the same protein primary sequence. Similarly, on a
structural level, as polymorphs for the same protein have different
residues involved in their cores, each will have a different flanking
region (Figure 3).
IDENTIFICATION OF SEQUENCES
INVOLVED IN FORMING AMYLOID
Prior to the development of high-resolution structural methods
capable of solving amyloid structures in atomic detail, lower
resolution techniques were employed to provide information
about the sequences that drive aggregation. These include
analysis of the ability of arrays of peptide fragments from
different amyloid precursor sequences to form cross-β amyloid-
like structures in isolation (Tenidis et al., 2000; von Bergen et al.,
2000; Jones et al., 2003a; Ivanova et al., 2004; Nelson et al.,
2005), scanning mutagenesis of a sequence followed by analysis
of fibril formation using aggregation assays (e.g., Thioflavin
T fluorescence) (Williams et al., 2006; Platt et al., 2008), and
determination of the sequences that form the stable amyloid
core, e.g., using protease digestion followed by mass spectrometry
(Miake et al., 2002; Myers et al., 2006; Kushnirov et al., 2020)
or HX monitored by 1H-NMR (Hoshino et al., 2002; Cho et al.,
2011; Strohäker et al., 2019). These experimental approaches
have been complemented by the development of in silico tools
(Ebo et al., 2020; Santos et al., 2020), able to identify APRs by
calculation of β-sheet propensity (using TANGO) (Fernandez-
Escamilla et al., 2004) or solubility (CamSol) (Sormanni et al.,
2015) (see Santos et al., 2020 for a recent review of these
and other approaches). Most, but not all APRs are found
in the fibril core. Residues that are found in fibril cores
determined by cryoEM or ssNMR and in the APRs identified
using computational methods described above are here defined
as “aggregation hotspots” (Figure 3). They often contain motifs
crucial for fibril formation [e.g., the Non-Amyloid β-Component
(NAC) region of αSyn, the 22NFGAIL27 sequence from human
islet amyloid polypeptide (IAPP), 15KLVFF20 for Aβ and
306VQIVYK311 from Tau].
Huge strides have been made in amyloid fibril structure
elucidation in the last decade using X-ray diffraction of
microcrystals (usually of short, 6–15 residue peptides) (Rodriguez
et al., 2015; Guenther et al., 2018), and, more recently, using
ssNMR and cryoEM of amyloid fibrils formed in vitro and
ex vivo from full-length proteins. These studies have shown
that the same sequence can produce fibrils with remarkably
different quaternary, tertiary and even secondary structural
elements (Gallardo et al., 2020b). For example, more than six
different amyloid fibril structures of the 140 residue protein,
α-synuclein (αSyn) have been solved to date using cryoEM or
ssNMR (Table 1; Guerrero-Ferreira et al., 2020; Schweighauser
et al., 2020). Notably, while the fibril cores in all of these
structures contain the NAC region known to be necessary and
sufficient for amyloid formation (Giasson et al., 2001), the
length and location of the sequence involved in the remaining
portions of structured amyloid core (or conversely the residues
involved in unresolved, dynamically disordered regions) varies
depending on the morphology of the amyloid fibril formed
(Figure 3; Guerrero-Ferreira et al., 2019, 2020; Schweighauser
et al., 2020). Thus, between 50% and 70% of the 140 residues
of this protein are not involved in the cross-β amyloid core.
A second striking example is the two fibril structures formed
from antibody light chains (LCs) that were extracted from two
patients with systemic LC amyloidosis (involving different LC
sequences). These studies revealed that these proteins with the
same initial immunoglobulin (Ig)-containing native structure
(Huang et al., 1996; Swuec et al., 2019), form completely different
amyloid fibril architectures, with residues 16–23 and 86–93
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FIGURE 2 | Flanking regions and amyloid formation. (A) Computational approaches can be used to identify aggregation-prone regions (APRs) from sequence data
alone (blue). Fibril cores are defined by cryoEM and ssNMR structures of amyloid fibrils and include residues that adopt a stable cross-β structure (purple). When the
APRs and the fibril core overlap, we term the region as an “aggregation hotspot” (red). Large segments of a protein sequence can remain dynamically disordered in
amyloid structures (lower image). (B) Interaction partners and/or (C) the formation of transient non-local intra-molecular interactions that involve regions that flank the
APRs can have significant effects on the aggregation kinetics of amyloidogenic proteins, as well as on their function. (D) Dynamically disordered regions flanking the
amyloid core in the fibrillar state form an amyloid “fuzzy coat” that can impart biological functions to the amyloid fold.
(Radamaker et al., 2019), or residues 1–37 and 66–105 forming
the core (Swuec et al., 2019).
In general, in silico-identified APRs (which may differ slightly
when using different algorithms) are shorter in length compared
with the experimentally determined fibril core using cryoEM or
ssNMR (Figure 3). It should be noted that in silico methods
also identify APRs that can reside outside the structured amyloid
core, and so form the flanking region of aggregation hotspots
(Figure 2A). A particularly striking example of this is seen in
the functional amyloid Orb2, associated with long term memory
formation and storage (Keleman et al., 2007; Majumdar et al.,
2012; Khan et al., 2015; Hervas et al., 2020), where there is
no overlap of sequence between residues in the experimentally
derived fibril core and those in APRs identified using in silico
methods (Figure 3F). This clearly demonstrates the division of
sequence motifs into those which may be kinetically important,
those which are thermodynamically important, and some which
play neither or both roles.
Similar to the diversity of amyloid flanking regions, it can also
be difficult to parse structured and unstructured regions. For the
functional amyloid protein Sup35, for example, which is involved
in controlling translation in yeast (Lyke et al., 2019), site-directed
mutagenesis and fluorescence labeling suggested that the amyloid
core comprises amino acids 21–121, flanked by a structurally
heterogeneous “transition zone” (residues 1–20 and 122–158),
and a very flexible C-terminal region formed by residues
159–250 (Krishnan and Lindquist, 2005). Another example of
different residual mobility of flanking regions was seen by
performing immunogold labeling and transmission EM, force-
volume measurements using atomic force microscopy (AFM)
and solution NMR experiments on Tau filaments (Sillen et al.,
2005; Wegmann et al., 2013). These experiments suggested that
the flanking regions of Tau form a “two layered polyelectrolyte
brush” surrounding the fibril core: a dense and mechanically
more rigid layer (residues ∼173–243) and an N-terminal, less
dense and more dynamic layer (residues∼1–172). The increased
exposure to solvent renders longer unstructured regions, such
as those in Tau and αSyn sensitive to environmental conditions:
Tau amyloid fibrils exhibit a 50% reduction in the rigidity
of flanking regions upon increasing KCl concentration from
50 mM to 200 mM and show increased affinity (70% higher
adhesion) to negatively charged membranes when lowering the
pH from 7.4 to 4.5 (Wegmann et al., 2013). These changes may
be relevant during lysosomal degradation (Wang et al., 2009).
Finally, while not part of the structured β-sheet rich fibril core,
some sequences in the flanking regions can nonetheless form
secondary structure as shown using ssNMR for the 17 amino acid
long N-terminal region (residues 4–11) of exon 1 of huntingtin.
In this case, the region flanking the aggregation-prone expanded
polyQ region adopts a solvent exposed and dynamic α-helical
structure (Sivanandam et al., 2011).
ROLE OF FLANKING REGIONS AND
AGGREGATION HOTSPOTS IN FIBRIL
FORMATION
Flanking regions have been shown to play roles in modulating
the rates and mechanisms of aggregation (Benilova et al., 2014;
Doherty et al., 2020). For example, point mutations linked
with early onset familial Parkinson’s disease (Mehra et al.,
2019) and ALS (Prasad et al., 2019) or post-translational
modifications (including phosphorylation, acetylation,
sumoylation, methylation, ubiquitination, glycosylation,
and truncations that alter aggregation kinetics) are often remote
from the APRs within these protein sequences (Figures 3A,B).
These regions also bind to other molecules such as chaperones,
nucleic acids, and membranes, and hence, can play functionally
important roles (Table 1). Consequently, these regions re-sculpt
the aggregation energy landscape (Figure 1) enhancing [or in
some cases suppressing (Jonsson et al., 2012)] aggregation and its
associated cytotoxicity, and can alter the function of the native
amyloid precursor. It is thus crucial to analyze these regions
when assessing amyloid formation mechanisms, rather than
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FIGURE 3 | APRs comprise only a small part of the amyloid core. Top in A–H: location of fibril cores of αSyn, TDP-43, Aβ, Tau, β2m, Orb2B, IAPP, and PrP defined
by recent cryoEM or ssNMR fibril structures (purple). The positions of familial disease mutations are highlighted where appropriate as black lines. Bottom in A–H:
regions with low solubility predicted by CamSol (below –1 is aggregation promoting highlighted in blue) (Sormanni et al., 2015) and the β-aggregation potential of
each sequence predicted using TANGO (Fernandez-Escamilla et al., 2004). (A) αSyn including polymorph 1a (1) (Guerrero-Ferreira et al., 2018; Li B. et al., 2018; Li Y.
et al., 2018) (core residues 37–99), 1b (2) (Li B. et al., 2018) (core residues 43–83), 2a and b (3) (Guerrero-Ferreira et al., 2019) (core residues 14–24, 36–96) and the
MSA ex vivo structures including residues 14–94 (for PF-IA and PF-IIA) (4) or residues 21–99 (for PF-IB and PF-IIB) (5) in the fibril core (Schweighauser et al., 2020).
(B) TDP-43 cryoEM structure solved from C-terminal segments forming a dagger shaped core (1) (residues 312–346) or R-shaped core (2) (residues 288–319) (Cao
et al., 2019). (C) Aβ structures solved (1) for Aβ42 (Gremer et al., 2017) and Aβ40 in which all residues comprise the core (Lu et al., 2013; Kollmer et al., 2019) (2)
fibrils in which the core is formed by residues 10–40 for Aβ40 (including polymorphs 2A and 3Q) (Petkova et al., 2002; Paravastu et al., 2008) and (3) for Aβ42 (core
formed by residues 15–42) (Colvin et al., 2016; Wälti et al., 2016). (D) Tau fibril structures PHF and SF from Alzheimer disease patients (1) (Fitzpatrick et al., 2017)
(core residues 306–378), NPF and WPF from Pick’s Disease (2) (Falcon et al., 2018) (core residues 254–378) and heparin induced structures 4R-s and 3R formed
in vitro (3) (core residues 272–330) and 4R-t and 4R-j (4) (core residues 274–292, 304–321, respectively) (Zhang et al., 2019). (E) The β2m fibril core involves residues
22–85 (Iadanza et al., 2018b; Gallardo et al., 2020a). (F) The Orb2B fibril core consists of residues 176–206 (Hervas et al., 2020). (G) Human IAPP forms fibrils with
residues 13–37 (Röder et al., 2020), 14–37 (Cao et al., 2020), or 13–37 (Gallardo et al., 2020a), with its early onset S20G variant adopting fibrils with two- and three
filaments involving residues 15–37 in the core (Gallardo et al., 2020a). (H) PrP fibrils form fibril core with residues 170–229 revealed using cryoEM (Wang et al., 2020).
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TABLE 1 | Summary of the functional roles of different regions of the amyloid proteins shown in Figure 3.
Protein Residues/region (Dys-)function References
αSyn
1–14 Membrane insertion Cholak et al., 2020
1–25 Initial membrane binding Fusco et al., 2014
Extreme N-terminus and region around
Y39
Chaperone binding Burmann et al., 2020
36–42 + 45–57 Involved in liposome clustering Doherty et al., 2020
36–42 + 45–57 Forms intra- and intermolecular interactions
important for fibril formation
Doherty et al., 2020
37–54 Forms β-hairpin crucial for
nucleation/oligomerization processes
Mirecka et al., 2014
C-terminal region (91–140) Protects protein from aggregation by
shielding NAC region and/or β-hairpin
C-terminal truncation (109-140) results in
faster aggregation
Hoyer et al., 2004; Hong et al., 2011;
Yu et al., 2015; Stephens et al., 2019
C-terminal region (residues 110–140) Binding to chaperone-like protein SERF
accelerates aggregation
Falsone et al., 2012
C-terminal region (residue 125–129) Dopamine binding drives off-pathway
oligomer formation
Herrera et al., 2008
TDP-43
3–183 Interactions initiate homodimerization
important for polymerization dependent
splicing activity
Shiina et al., 2010; Afroz et al., 2017
1–10 (especially Arg6, Val7, Thr8, and
Glu9)
Mediates full-length TDP-43 oligomerization
important for splicing activity and key to
initiate aggregate formation
Zhang et al., 2013
RRM1 (104–176), especially residue
I107, D105, L111, W113, Q134, G146,
F147, F149, R171, K176, N179 [RRM2
(192–262)]
Binds TG-rich DNA and UG-rich RNA for
function (e.g., splicing, translation control,
transport). RRM2 shows lower binding
affinity.
Lukavsky et al., 2013; Kuo et al., 2014
RRMI1 (residue F147 and F149) and
residue 208–441
Prevents aggregation by enhancing
solubility when bound to single stranded
RNA/DNA
Huang et al., 2013
RRM1 (residue F147 and F149) and
321–366
Autoregulation of own protein expression
by binding to its mRNA
Ayala et al., 2011
Residue 320–340, especially W334,
W385, and W412
Involved in liquid-liquid phase separation Conicella et al., 2016; Sun and
Chakrabartty, 2017; Li H.R. et al., 2018
Aβ
N-terminal domain (residues 1–17) Binding to cystatin C (cysteine protease
inhibitor)
Sastre et al., 2004
Aβ40: central region (residues 25–29);
part of the structured fibril core but
solvent accessible
Disaggregase activity when binding
Lipocalin-type Prostaglandin D synthase
(L-PGDS)
Kannaian et al., 2019
Tau
1–202 Binding to plasma membrane Brandt et al., 1995
N-terminal domain (1–150) interacts
with proline rich domain (151–244)
Dimerization (head to tail), suggested to be
the natural form for function and toxicity
Rosenberg et al., 2008
Residue 1–117 and 118–402 Electrostatic interactions between these
regions drive phase separation
Boyko et al., 2019
(Continued)
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TABLE 1 | Continued
Protein Residues/region (Dys-)function References
114–193 (P-rich domain) and 198–278
(microtubule-binding domain)
Actin binding and promoting F-actin
bundling and G-actin assembling
He et al., 2009
N-terminal domain, proline-rich region
and MBD
Chaperone binding Mok et al., 2018
Proline rich domain, MBD Interaction and polymerization of tubulin Barbier et al., 2019; Chen et al., 2019;
McKibben and Rhoades, 2019
Proline rich domain and C-terminal
domain
Main locations of phosphorylation sites,
but can be found throughout the whole
sequence
Liu et al., 2007
MBD (295–305) β-hairpin formation that protects the
aggregation prone 306–311 region
Chen et al., 2019
MBD (residue 275–280 and 306–311)
and other regions
Heparin binding drives aggregation;
MBD shows highest affinity to heparin
Sibille et al., 2006
β2m
Residue 1–6 Stabilization of native structure;
accelerates aggregation when deleted
Esposito et al., 2000
A and G strand (I7A, V9A, and V93A) Mutations drive fibril growth by
destabilizing local tertiary structure and
increasing dynamics
Jones et al., 2003b




oligomerization and fibril formation
Esposito et al., 2013
Orb2B
RNA binding domain Interaction with RNA facilitates long
term memory formation
Krüttner et al., 2012
IAPP
1–19 Membrane binding and disruption Brender et al., 2008
1–17 and/or 30–37 Liquid-liquid phase separation Pytowski et al., 2020
PrP
N-terminal region (residues 23–90) Interaction with Tau Han et al., 2006
N-terminal region (residue 23–89) Interaction with αSyn fibrils facilitating
αSyn cell-to-cell spreading
Aulić et al., 2017
Residues 95–110 Receptor binding site for
Aβ42-oligomers
Laurén et al., 2009
Hydrophobic region (residue 111–134) Hydrophobically driven
binding/insertion with anionic
membranes, this interaction is
important for (murine) PrP to gain
C-terminal Proteinase K resistance and
convert it to PrPSc
Wang et al., 2010b
Octapeptide region in N-terminal
domain
Increased numbers of octapeptides
that bind Ca2+ promotes fibril
formation and disease development
Goldfarb et al., 1991
Each protein sequence is coloured, highlighting regions with different functional activity or those which have been mapped biochemically. RRM, RNA recognition motif;
MBD, microtubule binding domain.
focusing solely on short peptide sequences that constitute the
APRs. The latter approach, however, can be incredibly fruitful,
leading to novel anti-microbial agents (Khodaparast et al., 2018)
and potential cancer treatments (Gallardo et al., 2016).The
latter study showed that a de novo designed peptide, vascin,
based on an amyloidogenic fragment of vascular endothelial
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growth factor receptor 2 (VEGFR2) knocked down VEGFR2 as a
consequence of VEGFR2-dependent fibril growth (Gallardo et al.,
2016). Importantly, aggregation kinetics can be either slowed
or accelerated depending on the protein and/or the precise
modification of the flanking sequences. This is particularly
apposite for IDPs, as the shallow, but rough, energy landscapes of
these proteins renders their conformational ensemble sensitive
to changes in their sequence and environment. This can result
in APRs or binding motifs being exposed or sequestered, which
in turn can accelerate, slow or prevent aggregation for the same
protein sequence relative to a reference condition. Changes
in pH, ionic strength and even being in a different cellular
environment (e.g., oligodendrocytes vs neurons) can thus have
a significant effect on fibril formation as shown for αSyn (Peng
et al., 2018; Stephens et al., 2019). Indeed, far from being passive
bystanders, flanking regions may be as important in defining the
physiological role and amyloid disease etiology as the canonical
APRs themselves (Figure 4). Here we highlight examples where
flanking regions are involved in promoting or disfavoring
aggregation to draw an overview of the significance of sequence
and interaction partners of amyloidogenic proteins and peptides
for fibril formation.
Flanking Regions That Protect Against
Aggregation
A protein concentration higher than the critical amyloid
concentration (Xue et al., 2008), and (sometimes) the presence
of surfaces that can act as nucleation sites are required to
overcome the energy barrier needed to form amyloid structures
(Buell, 2017). Such surfaces include membranes, other proteins,
or the air-water interface [so-called heterogeneous primary
nucleation (Buell, 2017; Figure 4)] or the amyloid fibril surface
itself (secondary nucleation) (Linse, 2017). In the crowded
cell, there is a fine-balance of expressing sufficient protein to
maintain function, but avoiding high expression levels to disfavor
aggregation. This strategy was described as “life on the edge”
by Dobson and co-workers (Tartaglia et al., 2007). Interestingly,
more recent work has shown that regions surrounding an
aggregation hotspot can play a role in maintaining the correct
balance between expression level and aggregation potential,
such that aggregation is disfavored, whilst the function of the
native protein is maintained. A particularly clear example is the
TAR DNA-binding protein 43 (TDP-43). The formation of a
negative feedback loop involving the RNA-recognition motif 1
(RRM1, especially residues F147 and F149) and the fibril core-
forming C-terminal region [residues 321–366 (Figure 3B)] self-
regulates protein expression via a mechanism in which TDP-43
binds its own mRNA leading to decreased protein expression
(Ayala et al., 2011; Table 1). Single stranded RNA (ssRNA) or
DNA (ssDNA) binding to the flanking regions of TDP-43 also
functions as a protective mechanism against amyloid formation
by increasing the solubility of TDP-43 (Huang et al., 2013).
In addition to translational control, the flanking regions of
TDP-43 have also been found to affect its aggregation kinetics
directly. For example, cells overexpressing 11–10 TDP-43 do
not form cellular inclusions, by contrast with cells producing the
full-length protein (Zhang et al., 2013). Another example where
flanking regions protect from aggregation is the homo-tetrameric
protein transthyretin (TTR), which is expressed in the liver and
cerebrospinal fluid and is associated with amyloidosis. For this
protein, the gatekeeper residue K35 [located just at the edge of
the fibril core of a recently solved cryoEM structure (Schmidt
et al., 2019)] protects the full-length protein from fibril formation
(Sant’Anna et al., 2014).
Flanking regions can also limit fibril formation by binding
to chaperones, which stabilize and protect the native state of
the protein (Wentink et al., 2019; Figure 4). Using in vitro
and in cell NMR Burmann et al. (2020) recently showed that
αSyn is bound to an array of molecular chaperones. Some of
these are physiologically relevant (e.g., hsc70, hsp90) whereas
others are not (e.g., the periplasmic bacterial chaperones Skp
and SurA). Similarly, the ATP-independent nascent polypeptide
associated complex (NAC) has been shown to bind to the flanking
regions of αSyn and ataxin 3 and retard their aggregation (Martin
et al., 2018; Shen et al., 2019). Despite their diversity, all six
chaperones in the study by Burmann et al. (2020) were found
to bind the N-terminal 10 residues of αSyn and a segment
around residue Y39 (Table 1). Inhibition of chaperones Hsc70
and Hsp90 in mammalian cells resulted in the re-localization
of αSyn from the cytosol to the mitochondria, amplified fibril
growth and increased membrane binding, which has been
shown to be the toxic form of αSyn in yeast (Newberry et al.,
2020). Interestingly, phosphorylation of Y39, which is associated
with αSyn-dependent neurodegeneration (Brahmachari et al.,
2016), decreased the interaction with chaperones. Enhancing
the concentration of various heat shock proteins thus disfavors
αSyn aggregation, potentially providing a therapeutic approach
to treat αSyn-aggregation and its associated cytotoxicity (Jones
et al., 2014). Similar aggregation-suppressive effects have been
reported for other chaperone:protein pairs: β2-microglobulin
(β2m) interacts with αB-crystallin mainly via its flanking regions
[residues 6–11, 21–28, 9–83 (Figure 3E and Table 1)] and some
residues within the APR (residues 64–70) (Esposito et al., 2013);
the N-terminal domain of Tau (residues ∼1–40) (as well as
the proline-rich region and repetition motifs [residues ∼160–
370 (Figure 3D and Table 1)] binds to the chaperone DnaJA2
(Mok et al., 2018) and the N-terminal 17 residue flanking
region of the huntingtin protein forms a complex with the
molecular chaperones Hsc70 (Monsellier et al., 2015) or TriC
(Tam et al., 2009) reducing its aggregation. This might be
explained by the fact that chaperones bind to flanking regions
preventing the formation of crucial conformations/interactions
required for amyloid formation. For instance, the exon 1
domain of huntingtin has been shown to initiate aggregation by
dimerization of its N-terminal 17 residues (Kelley et al., 2009)
which is inhibited by chaperone binding to this sequence (Tam
et al., 2009; Monsellier et al., 2015).
By contrast with the chaperones discussed above, other
chaperone-like proteins have been shown to accelerate
aggregation. For example, the binding of the human protein SERF
(or MOAG-4, the SERF homolog in Caenorhabditis elegans)
has been shown to accelerate aggregation of polyglutamine
peptides, huntingtin, Aβ and αSyn in vitro and in vivo (van
Frontiers in Neuroscience | www.frontiersin.org 8 December 2020 | Volume 14 | Article 611285
fnins-14-611285 November 27, 2020 Time: 13:11 # 9
Ulamec et al. Dynamic Disorder and the Amyloid Fold
FIGURE 4 | Factors affecting the conformational properties and interactions with amyloid precursors that retard or accelerate fibril growth. The two main influences
are sequence/conformation-dependent (left-hand side) or occur as a result of binding to interaction partners (right-hand side).
Ham et al., 2010; Falsone et al., 2012; Meinen et al., 2019).
Although the binding site on SERF for all of these amyloidogenic
proteins has yet to be identified, αSyn was shown to bind
via its C-terminal region (residues 110–140) (Falsone et al.,
2012). In other cases, binding of small molecules [chemical
chaperones (Figure 4)] has been shown to accelerate or to
retard the rate of aggregation and/or the morphology of the
fibrils formed. For example, the glycosaminoglycan heparin,
has been shown to induce the aggregation of Tau, resulting
in fibrils with a different structure from Tau fibrils extracted
from the brains of patients with Alzheimer’s, Pick’s or other
Tau-associated neurodegenerative disorders (Zhang et al.,
2019; Scheres et al., 2020; Figure 3D). NMR studies revealed
multiple binding sites on Tau for heparin, with binding
affinities ranging from 10 µM to the mM range. The tightest
binding is observed within the microtubule binding domain
(MBD) (residues 275–280 or 306–311), again highlighting that
binding outside the APR modulates aggregation (Sibille et al.,
2006). As a final example, the small molecule dopamine binds
the C-terminal region of αSyn (residues 125–129), driving
off-pathway oligomer formation that does not result in fibril
growth (Herrera et al., 2008).
Flanking Regions That Accelerate
Aggregation
As several amyloidogenic proteins are IDPs, transient intra-
or inter-molecular interactions mediated by flanking regions
can play an important role in defining the overall aggregation
propensity of a protein sequence by altering the solvent
accessibility of key APRs (Figure 4). For example, paramagnetic
relaxation enhancement (PRE) NMR and computational
modeling experiments revealed that the flexible negatively
charged C-terminal region of αSyn (residues 96–140) forms
intra- and inter-molecular interactions with the positively
charged N-terminal region of the protein, which protect the
aggregation-prone NAC region (Hong et al., 2011; Janowska et al.,
2015; Yu et al., 2015; Stephens et al., 2019; Table 1). Conditions
that disfavor these transient interactions [e.g., high cation
concentration (Nath et al., 2011), low pH (Hoyer et al., 2002)
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or familial Parkinson’s disease mutations (Ranjan and Kumar,
2017)] result in perturbation of the protective long-range
contacts and accelerate aggregation (reviewed by Stephens et al.,
2019). Likewise, truncation of the protective C-terminal region
of αSyn, as found in Lewy bodies in disease-associated brains
(Muntané et al., 2012), causes more rapid fibril formation,
potentially rationalizing the role of truncation of these regions
in the development of disease (Hoyer et al., 2004). Similarly, for
TTR the C and D strands (not part of the aggregation hotspot)
are involved in the interchain contacts that lead to aggregation
(Kelly and Lansbury, 1994; Palaninathan et al., 2008). Also, many
disease associated mutations of TTR (e.g., V30M and L55P) are
located within the C and D strand region (Murakami et al., 1992;
Lashuel et al., 1999).
More recently, studies analyzing the aggregation kinetics of
N-terminal deletion variants of αSyn have shown that specific
regions of the protein are also required for the aggregation of
full-length αSyn, building on an array of previous data that
suggested an importance of the N-terminal region of the protein
for its function (membrane binding) (Fusco et al., 2016; Cholak
et al., 2020) and its aggregation (Kessler et al., 2003; Terada
et al., 2018). Perhaps most remarkably, based on prediction of
aggregation-prone and insoluble regions (Figure 3A) discrete
sequences were identified that form a range of precise interactions
with residues in the NAC and C-terminal regions, protecting
the protein from aggregation (Doherty et al., 2020). Deleting
residues 38–61 (that encapsulates a region (residues 47–56)
shown by Eisenberg and Sawaya (2017), to form fibrils in
isolation and named the pre-NAC region (Rodriguez et al.,
2015), or deleting/replacing an even shorter peptide [named P1,
residues 36–42] or P1P2 (residues 36–57) results in significantly
slower fibril growth compared with the wild-type protein both
in vitro and in C. elegans models (Doherty et al., 2020). The
reduced aggregation rate may be a consequence of preventing
the formation of inter-molecular contacts between regions of the
IDP that form a transient β-hairpin structure (strand 1: residue
37–43 and strand 2: residue 48–54) previously postulated based
on Thioflavin T assays and molecular dynamics simulations
to drive aggregation (Mirecka et al., 2014; Yu et al., 2015).
In accord with this hypothesis, binding of a nanobody known
as a β-wrapin to this motif prevents aggregation in vitro
and in Drosophila (Mirecka et al., 2014; Agerschou et al.,
2019). Similarly, a specific short aggregation-modulating peptide
sequence that lies outside its APRs has been observed for
another IDP, Tau, but here the formation of a β-hairpin structure
involving residues 295–311 protects the aggregation hotspot
[residues 306–311 (Figure 3D)] by using the flanking region
295–300 as a protective shield. Familial point mutations or
alternative splicing can result in weakening of this secondary
structural element, exposing the APR and promoting aggregation
(Chen et al., 2019). Finally, for apolipoprotein apoA-I, involved
in systemic amyloidosis, the aggregation hotspot (residues 14–
22) is protected by a helix bundle formed at the N-terminus
of the protein. Familial amyloidosis associated with disease-
promoting mutations (such as G26R, W50R, F71Y, or L170P),
all of which are located in regions flanking the amyloid hotspot,
induce conformational changes that result in exposure of residues
14–22 and lead to amyloid formation (Adachi et al., 2014;
Das et al., 2016).
The aggregation of globular proteins can also be affected
by their flanking regions. One well-understood example is β2-
microglobulin (β2m, a 99-residue protein with an Ig fold when
natively folded) which is associated with the disease dialysis-
related amyloidosis (DRA) (Gejyo et al., 1986). Approximately
30% of the molecules in fibrils of DRA patients is comprised
of an N-terminally truncated variant missing the N-terminal
six residues (Esposito et al., 2000). This deletion variant which
is significantly more aggregation-prone than the full-length
protein, is destabilized in its native state, and exhibits increased
dynamics that facilitates amyloid formation (Chiti et al., 2001;
Jahn et al., 2006; Eichner et al., 2011; Karamanos et al.,
2019). An in vitro study that introduced point mutations into
different β-strands of β2m further showed the importance of A-
(residues 6–11) and G-strands (residues 91–94), both distant to
the aggregation hotspot (Figure 3E). Amino acid substitutions
in these strands (I7A, V9A, or V93A) induced aggregation
by destabilizing the monomeric structure specifically in these
regions, while similar mutations elsewhere in the sequence
caused similar loss of thermodynamic stability, yet did not drive
aggregation (Jones et al., 2003b). Hence local, rather than global,
stability, is important in tailoring the aggregation of natively
folded proteins, potentially because of the specific effects this
has on fulfilling the aggregation-potential of a sequence’s APRs
(Langenberg et al., 2020). In a similar vein, a rare mutation in
β2m has recently been discovered in a French family that results
in a different amyloid disease in which the variant protein (D76N)
forms fibrils that deposit in the viscera without loss of renal
function (Valleix et al., 2012). Importantly, the substituted amino
acid (D76N) lies in a solvent exposed loop distant to the single
APR in the protein (Figure 3E).
Other globular proteins have also been found to have
flanking regions that are critically important for aggregation,
including polyglutamine expansion (polyQ) proteins such as
ataxin-3 (Saunders and Bottomley, 2009). This ∼40 kDa protein
has a structured N-terminal protease domain (the Josephin
domain) followed by an IDR which contains two (or sometimes
three) ubiquitin interacting motifs (UIMs) and an expanded
polyQ tract (Paulson, 2012). The aggregation mechanism of
ataxin 3 in vitro has been shown to involve two kinetically
resolved stages. In the first phase, the aggregation-prone Josephin
domain self-associates into worm-like fibrils (that lack the cross-
β structure of amyloid), with the slow formation of amyloid
involving the polyQ tract occurring in a second phase (Ellisdon
et al., 2006). Like all polyQ proteins, aggregation of ataxin
3 is critically dependent on the length of the polyQ tract.
Importantly, the presence of a long (disease-causing) poly-
glutamine tract changes the conformational dynamics of the
Josephin domain, exposing the aggregation-prone N-terminal
region and allowing self-association that results in aggregation
(Gales et al., 2005; Scarff et al., 2015). Akin to the results
for the mutation causing β2m aggregation discussed above,
the polyQ tract is believed to diminish the stability of
neighboring domains in ataxin 3, creating a local denaturing
environment (Ignatova and Gierasch, 2006). The longer the
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polyQ sequence, the greater its effect in accelerating aggregation
(Scarff et al., 2015).
In addition to intra- and inter-molecular homotypic
association, interactions of flanking regions with other
molecules/surfaces (heterotypic interactions) can also affect
the kinetics of fibril formation (Sarell et al., 2013; Figure 4). For
several amyloidogenic proteins, including IAPP, Aβ40/42 and
αSyn, aggregation is accelerated in the presence of membranes
(Terakawa et al., 2018). For example, the N-terminal region of
αSyn binds to lipid bilayers (forming an α-helical structure) that
leads to extensive surface-induced fibril growth (Fusco et al.,
2014; Doherty et al., 2020; Table 1). For IAPP, the N-terminal
19 residues (which flank the core region of amyloid involving
residues ∼15–37) bind to membranes and also become helical
(Brender et al., 2008). Studies on an N-terminal fragment of
IAPP involving residues 1–19 showed that membrane binding
and disruption of the bilayer occur independently of fibril
formation (Brender et al., 2008). Tau has also been shown to
bind membranes, having functional as well as pathogenic effects
where the lipid bilayer facilitates protein-protein interactions
driving aggregation (Elbaum-Garfinkle et al., 2010). Another
example where binding to membranes initiates a critical process
can be found for PrP, a GPI anchor protein, as binding and
insertion into lipid membranes (in the presence of RNA) initiates
the conformational transition to a highly aggregation-prone
form of PrP (Wang et al., 2010a). In addition, binding of PrP to
anionic phospholipids is mediated by a flanking region outside
of the fibril core and comprises the contiguous positively charged
(residues 100–110) and “hydrophobic domain” regions (residues
111–134) (Wang et al., 2010b). Surface-induced aggregation is
also important in the growing field of nanotechnology where
nanoparticles coated with sugars, lipids or proteins, are widely
used in drug delivery or diagnostics. These surfaces can also
enhance protein aggregation. For example, β2m has been shown
to aggregate more rapidly in the presence of copolymer particles,
cerium oxide particles, quantum dots, and carbon nanotubes
in a manner that is dependent on the surface area and surface
modification (Linse et al., 2007). Fibril formation of IAPP
is also enhanced in the presence of chiral silica nanoribbons
(Faridi et al., 2018).
Fibril formation of one protein can also be affected by
interactions with other amyloidogenic proteins. For example,
αSyn aggregation is enhanced in the presence of Tau, which is
biologically relevant since these two proteins are observed to co-
aggregate in inclusions in brains from patients with Dementia
with Lewy Bodies (DLB) (Colom-Cadena et al., 2013). Similarly,
CsgA, a bacterial functional amyloid, also accelerates αSyn
aggregation, possibly explaining clinical and epidemiological
data that show an accumulation of aggregated αSyn first being
found in olfactory epithelium or gastrointestinal tract, before
spreading to the brain (Sampson et al., 2020). Aggregation
assays with a C-terminally truncated variant of αSyn using PRE
NMR experiments revealed that the C-terminal region of αSyn
interacts with Tau (Dasari et al., 2019; Lu et al., 2020; Table 1).
This region is also involved in ion binding, most importantly
Ca2+, which drives fibril formation probably by changing the
conformational dynamics of αSyn to a more extended form
(Han et al., 2018). In vivo assays have shown that the native
prion protein (PrPC) or protease-resistant isoform (PrPSc) bind
Tau with their N-terminal disordered segment (residue 23–90)
(Han et al., 2006), and also bind to Aβ oligomers and αSyn
fibrils, facilitating cell surface binding and cell-to-cell spreading
(Laurén et al., 2009; Aulić et al., 2017). Additionally, single
molecule Förster resonance energy transfer experiments (FRET)
measuring the conformational ensemble of Tau have shown
that heparin induces conformational changes that could be
important in promoting amyloid formation (Elbaum-Garfinkle
and Rhoades, 2012). These involve a loss of long-range contacts
of the N- and C-terminal regions and a compaction of the
aggregation-prone MBD (Elbaum-Garfinkle and Rhoades, 2012).
Finally, post-translational modifications including
phosphorylation, ubiquitinoylation or acetylation are important
regulatory modifications of amyloidogenic proteins that
influence cellular mechanisms, such as protein degradation,
signaling or protein-protein interactions, and also lead to
misfolding and aggregation (Figure 4). Examples include
the 441-residue protein Tau, in which 85 residues have been
identified as phosphorylation sites mainly located in the
aggregation hotspot that flanks the proline rich and C-terminal
domains. Hyperphosphorylation of Tau is believed to trigger
its dissociation from microtubules and to drive amyloid
formation (Liu et al., 2007). However, recent studies on the
four repeat region (K18) of Tau suggest an inhibitory effect
of phosphorylation on fibril formation (Haj-Yahya et al.,
2020). Finally, the protein huntingtin contains three lysines
(K6, K9, K15) in its N-terminal 17-residue region which are
often ubiquitinylated or SUMOylated, reducing toxicity by
protease degradation or monomer stabilization, respectively
(Ehrnhoefer et al., 2011).
Roles of Flanking Regions in Protein
Function
As proteins associated with amyloidosis have functional roles in
their soluble states, aggregation can lead to a loss of function,
as well as a gain of toxic function. For example, Tau (Table 1)
is known to be present in six different isoforms in the central
nervous system formed by alternative splicing processes. This
results in deletions in the N-terminal region (45–103) or one of
the four repeat regions, R2 (residues 275–305) (Himmler et al.,
1989). The expression and translation levels of these isoforms
are correlated with different developmental stages (Kosik et al.,
1989), pointing to discrete functional roles of each. Indeed, Tau’s
main function is to bind microtubules with its aggregation-
prone MBD (residues 244–371) which induces assembly of
microtubules. Although the MBD is primarily responsible for
microtubule binding, its N-terminal and C-terminal flanking
regions have been shown to modulate the conformation and
accessibility of the MBD as part of its functional activity (Goode
et al., 2000; Barbier et al., 2019). Further, the proline rich
region (residues 151–243) (Table 1) also contributes to tubulin
binding and its polymerization into microtubules (McKibben and
Rhoades, 2019). Other amyloidogenic proteins such as αSyn are
also considered to be microtubule-associated proteins (MAP). In
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this case much less is known, with current research suggesting
a microtubule-polymerizing activity when αSyn binds tubulin
via its C-terminal region (Alim et al., 2004), or supporting
microtubule association and dynamics by binding probably via its
N-terminal- and NAC-regions adopting a helical conformation
(Cartelli et al., 2016). Oligomeric αSyn on the other hand has been
shown to inhibit tubulin polymerization, resulting in cell death
(Chen et al., 2007).
αSyn not only interacts with tubulin, but it also binds to
many different proteins and molecules that are important for
function (e.g., interaction with receptors to increase the neuronal
levels of dopamine or inhibiting SNARE complex formation) and
toxicity (e.g., the binding of αSyn to Parkin contributes to the
pathophysiology of Parkinson’s disease) (Emamzadeh, 2016). The
aggregation-prone NAC region of αSyn itself has been implicated
in its function [e.g., binding to the dopamine receptor in neurons,
regulating dopamine concentration (Lee et al., 2001)]. The ability
of αSyn to bind to membranes is key to its physiological function
of remodeling membrane vesicles within the presynaptic termini
(Diao et al., 2013). In vitro NMR studies of αSyn:liposome
interactions revealed that the N-terminal 25 residues trigger the
interaction with the membrane by acting as an anchor motif,
initializing binding of the whole N-terminal and NAC region
(membrane sensor region, residues 26–98) with the formation
of α-helical structure throughout this region (Fusco et al., 2014).
Residues 26–98 are believed to modulate the affinity of αSyn for
membranes and are crucial for its function in clustering synaptic
vesicles (Fusco et al., 2016). Deleting or replacing residues 36–
57 (the P1 and P2 regions discussed above), which flank the
aggregation hotspot, showed an inhibition of the membrane
remodeling activity, supporting a role of these flanking regions
in liposome fusion (Doherty et al., 2020). A study from Cholak
et al. (2020) suggests that the very N-terminal region (residues
1–14) of αSyn inserts into membranes to initiate membrane
binding, with N-terminal acetylation of αSyn enhancing the
lifetime of the membrane-bound state. In accord with the
functional importance of these regions, αSyn shows higher
sequence similarity to its two known homologs (βSyn and γSyn)
in the N-terminal region compared with the C-terminal region
(90% and 77% sequence identity in the N-terminal region and
36% and 1% sequence identity in the C-terminal region between
αSyn and βSyn and αSyn and γSyn, respectively) (George, 2001).
Membrane binding is not only involved in αSyn function, but it
also represents a risk factor for αSyn aggregation and cytotoxicity,
as association with membranes accelerates αSyn fibril formation
(Galvagnion et al., 2016; Fusco et al., 2017). Binding to lipid
bilayers via its N-terminal helical region has been suggested to be
the pathological conformation of αSyn in yeast, causing slower
cell growth and cell death (Newberry et al., 2020). Similarly,
binding to mitochondrial membranes resulted in cytotoxicity
due to enhanced formation of mitochondrial reactive oxygen
species (ROS) and reduced ATP levels (Vicario et al., 2018;
Ganjam et al., 2019).
The functional amyloid Orb2B is involved in forming long
term memories (Keleman et al., 2007; Majumdar et al., 2012;
Khan et al., 2015) by affecting translation within neurons
(Krüttner et al., 2012) via its RNA binding domain (RBD). The
RBD flanks a glutamine-rich region that drives the formation
of fibrils whose formation activates translation (Hervas et al.,
2020). TDP-43 is involved in maintaining mRNA stability,
maturation and transport via specific RNA-recognition motifs
(residues 104–262) (Prasad et al., 2019). For splicing, TDP-43
functions as a dimer stabilized by inter-molecular interactions
in the N-terminal region, especially the N-terminal 10 residues
(Shiina et al., 2010; Zhang et al., 2013; Afroz et al., 2017).
These intermolecular interactions are also involved in initiating
aggregation (Zhang et al., 2013), providing a further example
of the tug-of-war between sequences involved in function
that also enhance aggregation. TDP-43 also exhibits reversible
liquid-liquid phase separation, a reversible process of de-
mixing fluids into two distinct liquid-phases [reviewed by
Alberti et al. (2019) and de Oliveira et al. (2019)] important
for the formation of stress granules that store mRNA:protein
complexes under cellular stress (e.g., oxidative or thermal stress)
(McDonald et al., 2011; Sun and Chakrabartty, 2017). This
function is mediated by the C-terminal prion-like domain of
TDP-43 (Table 1). Substitution and deletion variants identified
Trp334, Trp385, and Trp412 as important drivers of phase
separation (Li H.R. et al., 2018). These residues flank the
aggregation hotspot of TDP-43 [residues 288–346 (Figure 3B)]
and only Trp334 is part of the fibril core in the dagger
shaped polymorph (Cao et al., 2019). TDP-43 liquid droplets
remain stable for only a short period of time (timescale
of hours) before transforming into irreversible aggregates
(Conicella et al., 2016). Using PRE NMR experiments, Conicella
et al. (2016) identified residues 321–340 as those responsible
for the crucial interactions for phase separation, by forming
inter-molecular helix-helix self-assemblies that are disrupted by
the ALS-associated mutations (A321G, Q331K, and M337V).
Tau also undergoes liquid-liquid phase separation prior to
the formation of gel-like and then amyloid-like aggregates
(Wegmann et al., 2018). A detailed study of deletion variants
revealed that electrostatic interactions between the N-terminal
region (residues 1–117) and parts of the C-terminal domain
(residues 118–402) drive phase separation [whereas residues in
the microtubule binding region are thought to be important
for amyloid formation (Elbaum-Garfinkle and Rhoades, 2012)].
Deleting either one of the former regions ablated droplet
formation (Boyko et al., 2019). Other amyloid-associated proteins
also undergo phase separation, at least in vitro (Elbaum-
Garfinkle, 2019). For example, liquid-liquid phase separation of
IAPP is catalyzed by the air-water-interface (Pytowski et al.,
2020). Interestingly, Comparison with the non-fibrillogenic rat
IAPP revealed that phase separation does not require the
presence of the highly amyloidogenic region (residue 20–29),
but hydrogelation and aggregation do (Pytowski et al., 2020).
The prion-like functional amyloid Sup35 also undergoes phase
separation, generating protein-specific environmental responses.
In this protein, the N-terminal prion domain, as well as the
flanking M-domain, have a benign role: promoting reversible
phase separation and gelation in a pH dependent manner
(Franzmann et al., 2018). Finally, αSyn has also been shown to
form phase separated droplets which precede aggregation into
amyloid in vitro and in cells (Ray et al., 2020) The cellular
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droplets later transform into perinuclear aggresomes, with the
familial mutations and phosphorylation of Y39 as discussed
above promoting liquid-liquid phase separation, as well as
aggregation into amyloid.
REGIONS FLANKING THE STRUCTURED
CORE OF AMYLOID FIBRILS: THE
IMPORTANCE OF THE INVISIBLE
FLANKING REGIONS
The biophysical and biochemical properties of each amyloid
fibril polymorph and their effect on cells can differ dramatically.
As amyloid formation is under kinetic control, changes in
the protein sequence and/or the assembly conditions (in vitro
or in cells) can affect the structure of the fibrils formed.
Accordingly, different fibril structures for Tau isotypes have
been observed to form in different amyloid diseases (Scheres
et al., 2020). Interestingly, for αSyn amyloid, heterogeneity is
also observed for fibrils from patients with Parkinson’s disease or
Multiple system atrophy [detected using ssNMR and differences
in the fluorescence emission spectra of extrinsic fluorophores
(Strohäker et al., 2019)]. The ability to discriminate polymorphs
by comparison of fluorescence emission spectra of some extrinsic
fluorophores (e.g., Thioflavin T or Congo Red) when intercalated
into cross-β fibril structures has been noted previously (reviewed
by Bhattacharya and Mukhopadhyay, 2016). The differential
binding affinity for some antibodies to oligomers and mature
fibrils also highlights the structural conversion that has to occur
for amyloid fibrils to form. For example, the Aβ42 antibody anti-
Trx(Aβ15)4 recognizes a structural epitope of oligomers and
fibrils but not of the monomer, with the same selectivity for other
amyloidogenic proteins (Moretto et al., 2007). Consequently, it is
perhaps not surprising that fibrils with different structures may
induce different effects in vivo. Ferrari et al. (2020), for example,
used a pull-down approach with FLAG-tagged Tau to show that
different aggregation stages (monomer, oligomer, fibril) have
altered reactivity with its cellular environment due to large
conformational changes that occur when this natively unfolded
protein self-assembles into a β-sheet rich fibrillary protein
state. Given that the “fuzzy coat” of disordered peptide regions
that flank the cores of amyloid fibrils can vary between fibril
polymorphs (Gallardo et al., 2020b), the effect of these dynamic
regions on the function, toxicity and further amplification
of the fibrils themselves may also vary, perhaps rationalizing
the epigenetic difference in disease development in individuals
expressing the same aggregation-prone proteins. Below we
discuss the importance of these structurally “invisible” flanking
regions in amyloid formation and the cellular consequences of
these regions in amyloid deposition (Figure 5).
Fibril Elongation, Secondary Nucleation
and Seeding
The extent of protein incorporation into insoluble fibrils is
controlled by processes such as seeding (fragments broken
off from fibrils, creating new fibril ends), elongation (the
FIGURE 5 | Schematic of interactions between the dynamically disordered
regions of fibrils and other molecules. Dynamically disordered regions
displayed on the surface of ordered amyloid fibrils can play roles in their
function and cellular dysfunction. (A) The fibril “fuzzy coat” could capture
amyloid precursors and facilitate their self-assembly into amyloid by (B)
secondary nucleation or other molecular events. (C) Interaction with other
(non-)amyloidogenic proteins could inhibit or alter their function.
(D) Interaction with membranes can result in a toxic mechanism involving
membrane disruption. (E) Interaction with chaperones can result in fibril
depolymerization. (F) Interaction with RNA has been observed in a functional
context for the protein CPEB (cytoplasmic polyadenylation element binding)
which regulates long-term memory (Khan et al., 2015; Hervas et al., 2020). In
other cases, disruption of cellular RNA could enhance phase separation and
lead to cellular toxicity and/or dysfunction.
addition of monomers or oligomers onto fibril seeds) and
secondary nucleation (creation of new nucleation sites on pre-
existing fibril surfaces) (Michaels et al., 2018; Shvadchak et al.,
2018; Scheidt et al., 2019). These kinetic events that drive
amyloid formation could depend on the monomeric amyloid
precursor, the structured amyloid core and the nature of the
fibril “fuzzy coat.” For example, the flanking regions may
be involved in the prion-like ability of αSyn to spread and
seed further fibril growth (summarized by Longhena et al.,
2017) as secretion of αSyn into the extracellular space occurs
in association with membrane vesicles for which binding of
the N-terminal region of αSyn is crucial (Emmanouilidou
et al., 2010). The elongation rate may be accelerated as the
large volume “fuzzy coat” may form transient interactions,
“capturing” incoming monomeric protein molecules (Tompa,
2009; Figure 5A). This model is supported by the example of
the human Prion Protein (PrP), in which increased numbers
of an octapeptide Cu2+-binding motif in the N-terminal IDR
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(which flanks the folded C-terminal prion domain) promotes
fibril formation and disease development (Goldfarb et al., 1991).
Additionally, the fibril surface might have a key role in surface-
induced secondary nucleation (Figure 5B). This is because
the surfaces of all but one (Gremer et al., 2017) amyloid
fibril structures solved to date are decorated by potentially
large region of dynamically disordered protein flanking regions.
Secondary nucleation for αSyn and other amyloid proteins,
including Aβ and IAPP, is strongly dependent on pH (Gaspar
et al., 2017). This could be explained by fact that the pH
affects the dynamics of the solvent exposed flanking regions,
as well as the charge along the ordered fibril core (Wegmann
et al., 2013). The importance of flanking regions for these
processes is illustrated by co-incubation of αSyn and βSyn.
NMR analysis of the fibrils formed show increased dynamics
in the N-terminal region compared with pure αSyn fibrils,
whilst the core structure is unchanged. These co-incubated
fibrils exhibited a reduced seeding capacity (Yang et al., 2019).
However, the precise molecular mechanism(s) of the elongation
and secondary nucleation processes, and how they alter with
changes in sequence and fibril structure is not currently
understood in detail.
Interaction With Other Amyloidogenic
Proteins
Amyloid fibrils can interact with other amyloidogenic precursors
and alter their amyloid potential (Figure 5C). αSyn fibrils, for
instance, have been shown to bind Tau monomers via the
αSyn acidic C-terminal region which is dynamically disordered
in all fibril structures determined to date (Guerrero-Ferreira
et al., 2020; Schweighauser et al., 2020). Since binding of Tau
stabilizes microtubules, αSyn fibrils indirectly affect microtubule
stability by removing Tau from microtubule surfaces resulting
in neuronal dysfunction (Oikawa et al., 2016). Interaction of
αSyn fibrils with Tau monomers further induces a conformational
change in Tau, promoting its subsequent assembly into Tau
amyloid structures (Oikawa et al., 2016). As reviewed by Luo
et al. (2016), Aβ interacts with at least 10 other disease-
related amyloidogenic proteins (e.g., IAPP, Tau, αSyn). For
example, aggregation of Aβ40/42 is inhibited by cystatin C
(Sastre et al., 2004), a protein which also colocalizes with
Aβ40/42 in brain amyloid deposits. ELISA assays with an
antibody targeting the N-terminal end of Aβ (residues 1–
17) defined the binding site to be the first 17 residues, since
binding was abolished in the presence of the antibody (Sastre
et al., 2004). Aβ40/42 aggregation is also inhibited in the
presence of TTR tetramers. NMR experiments revealed the
interaction site to be between the thyroxine binding pocket
of the TTR tetramer and Aβ residues 18–21 (Li et al., 2013).
Finally, amyloid proteins have been observed to interact with
other proteins in the context of cross-seeding. For example,
pre-formed fibrils of IAPP have been shown to cross-seed
Aβ40 monomers, accelerating fibril growth (Moreno-Gonzalez
et al., 2017). The exact binding site is not known, but
the two proteins have been shown to co-localize in disease
(Moreno-Gonzalez et al., 2017).
Membrane Binding
Although many studies have shown that oligomers can be
cytotoxic and possibly a major culprit of amyloid diseases
(Fändrich, 2012; Verma et al., 2015; Fusco et al., 2017; Karamanos
et al., 2019), the surface-induced fibril growth process on
membranes (Engel et al., 2008; Qiang et al., 2015) and the
interaction of mature fibrils with membranes (Figure 5D) have
both been shown to disrupt cellular function and homeostasis
(Martins et al., 2008; Xue et al., 2009; Pieri et al., 2012).
In vitro experiments on αSyn have shown that its kinetics of
aggregation are strongly affected by the presence of liposomes,
highlighting the important role of lipid bilayers for fibril
formation (Galvagnion et al., 2015). αSyn fibrils (and oligomers)
bind negative, but not neutrally charged, liposomes (Grey
et al., 2011; Pieri et al., 2012), pointing to an interaction
with the N-terminal positively charged flanking region, which
is dynamically disordered in the fibrillar state, similar to the
interaction that is observed in the monomeric state. Striking
work from Bäuerlein et al. (2017) used cryo-electron tomography
in situ to show that polyQ fibrils (from huntingtin-exon 1)
interact with membranes of the endoplasmic reticulum, changing
the dynamics and structural organization of the organelle. These
studies also showed that the sides of the fibril, as well as fibril ends,
interact with membranes, although which regions of the fibril
are involved in the interaction (the core or dynamic sequences)
is not currently known. Similar vesicle membrane disruption
was observed in vitro for β2m fibrils, with the majority of fibrils
binding via their ends (Milanesi et al., 2012). Interestingly, the
most severe membrane damage was observed for membranes
containing the lipid BMP [bis(monoacylglycero)phosphate]
which is enriched in lysosomal membranes, rationalizing the
role of this organelle in the etiology of many amyloid diseases
(Goodchild et al., 2014).
Interaction With Chaperones
Amyloid fibrils have been shown to interact with chaperones
in different contexts (Figure 5E) of which neuroprotection is
one of the foremost (Kannaian et al., 2019). Chaperone binding
functions as an inhibitor for primary nucleation (when binding
monomers), as well as for secondary nucleation and elongation,
and some chaperone systems can even induce disaggregation of
fibrils in the presence of ATP (Kannaian et al., 2019). Chaperones
such as αB-crystallin have been shown to bind along the length of
the fibril surface, perturbing secondary nucleation and elongation
for both Aβ40/Aβ42 and αSyn (Waudby et al., 2010; Shammas
et al., 2011). However, despite the authors revealing fascinating
images of the chaperone in situ using immunogold labeling and
immunoelectron microscopy, the exact binding site could not
be determined due to the low resolution of this technique. In
the case of Hsp27, which binds on the surface of αSyn fibrils
causing decreased cytotoxicity and inhibited elongation, total
internal reflection fluorescence (TIRF)-based imaging suggested
that Hsp27 preferentially binds to hydrophobic patches along
the fibril surface (Cox et al., 2018). These hydrophobic motifs
involved in the interaction could involve the dynamic regions
[residues 1–6 or 36–42 (Figure 3A)] as well as the fibril core
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itself. A higher resolution analysis, e.g., using HX methods, or
more directly using ssNMR, is required to identify the exact
chaperone binding sites.
Given the high thermodynamic stability of fibrils, it is
perhaps a remarkable feat that chaperones can induce their
depolymerization. For αSyn fibrils, for example, Bukau and
coworkers have shown that the human chaperone Hsc70,
specifically in complex with DNAJB1 (Hsp40 family) and Apg2
is a hsp110 family member (but not other co-chaperones from
these families), induces ATP-dependent fibril fragmentation and
depolymerization (Gao et al., 2015). Experiments using deletion
variants allowed the interaction site of the fibrils with the
chaperones to be identified, involving residues 1–30 and 111–
140: the flanking regions of the αSyn amyloid core. A similar
disaggregase activity has been observed for the Lipocalin-type
Prostaglandin D synthase (L-PGDS) and Aβ40 fibrils (Kannaian
et al., 2019). L-PGDS binds to the central region of the
Aβ40 sequence (G25–G29). As this sequence forms a bend
connecting two β-strands (Petkova et al., 2002) it is part of
the structured fibril core (Figure 3C), yet is solvent accessible.
L-PGDS fulfils its chaperone activity without ATP consumption
or any co-chaperones. Also, the protease HTRA1S328A can act
as a chaperone and disassemble pre-formed 4R Tau filaments
(Poepsel et al., 2015). Such observations may provide exciting
new strategies to reduce the fibril load in amyloid diseases
involving intracellular amyloid deposition.
Interaction With RNA
Several amyloidogenic proteins and prions have been identified
in the context of RNA-modulating functions (Nizhnikov et al.,
2016). Usually, as in the case of TDP-43, the native monomeric
protein is involved in binding the RNA (see above). However,
fibrils can also interact with RNA, as shown for the functional
amyloid CPEB, that is involved in long term memory formation
(Keleman et al., 2007; Majumdar et al., 2012; Khan et al., 2015).
A study on the Drosophila melanogaster CPEB homolog, Orb2B,
demonstrated that RNA binding to the monomeric protein
represses protein translation of some genes, whilst binding to
oligomeric states and fibrils activates protein production by
stabilizing and elongating the poly(A) tail of mRNA in neurons
in complex with other proteins (e.g., CG4612) (Khan et al.,
2015; Hervas et al., 2020; Figure 5F). Translation activation
changes the synthesis of specific synaptic proteins involved in
memory formation. A high resolution cryoEM fibril structure
demonstrated that only a small part of the Orb2 sequence
(residues 176–206) forms the fibril core (Figure 3F). The
RNA-recognition motif and protein interaction domain are
located in the long flanking regions of this 704 residue protein
(Hervas et al., 2020).
DISCUSSION
In this review we have discussed the roles of regions that flank the
APR sequences in monomeric amyloid precursors, and the role
of the dynamically disordered regions that flank the structured
core of amyloid fibrils in the interaction with other molecules
and how this impacts cellular (dys)function. The importance
of APRs is well recognized and their prediction using various
computational tools is now straightforward. How the sequences
that flank the APRs affect the kinetics and mechanisms of
fibril growth, the structures of fibrils that ultimately form, and
the extent and chemical identity of the dynamically disordered
“fuzzy coat” regions of fibrils is still not well understood. This
understanding is important as flanking regions play vital roles
in the formation and interaction of amyloid with the cell and
hence in disease.
In several native amyloid precursors, whether initially
disordered or structured, regions surrounding the APRs or
aggregation hotspot have been shown to be crucial for
modulating amyloid formation. Intrinsic interactions in IDPs,
including the APR flanking regions, can either promote or
disfavor aggregation, by altering the conformational landscape
of the IDP and “switching” amyloid formation on or off,
as clearly shown for αSyn, Aβ, and Tau (Elbaum-Garfinkle
and Rhoades, 2012; Stephens et al., 2019; Doherty et al.,
2020). Also, for initially natively folded proteins, such as
β2m, regions that flank the APRs often stabilize the native
conformation. Mutations or truncations in these regions can
consequently release the aggregation potential of the APR by
locally destabilizing the protein fold leading to fibril formation
(Langenberg et al., 2020). Advanced biophysical methods, such
as NMR PRE experiments and single molecule FRET analysis
can be used to identify transient long-range interactions in IDPs
and IDRs in all-residue, if not all-atom, detail. Complemented
by molecular dynamics simulations and experiments using
deletion or substitution variants, these approaches have helped
to identify the role of these “master controller” (Doherty
et al., 2020) motifs for amyloid formation and provide
targets to develop new strategies to combat amyloid formation
and disease (Mirecka et al., 2014; Agerschou et al., 2019;
Chen et al., 2019).
In addition to homotypic intra- and inter-molecular events,
interactions with other molecules can be vital for amyloid
function and pathology. Determining the interaction site of an
amyloidogenic protein, or an amyloid fibril, with other molecules
can be challenging, given the dynamic nature of the proteins
involved. However, NMR experiments using PREs or chemical
shifts, or binding assays with deletion variants can enable the
identification of the residues that are involved in these binding
processes. Such experiments can be used to clarify whether the
aggregation hotspot or its flanking regions are required for the
interaction, and potentially provide an evolutionary explanation
for the development of such high-risk sequences.
Proteins undergo dramatic conformational changes on the
pathway from initial precursor to amyloid states. More focus on
these structural changes and which parts of the protein sequence
drive these transformations might further demonstrate a crucial
role of flanking regions in the amyloid cascade. Flanking regions
of the fibril core are relatively straightforward to identify (e.g.,
using HX or protease protection experiments) but are especially
hard to analyze structurally since their dynamic properties
displayed on a static high molecular weight fibrillar particle
provide significant experimental and computational challenges.
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All high-resolution structural information on amyloid fibrils
formed from intact proteins [rather than short peptides and
peptide fragments (Guenther et al., 2018; Rodriguez et al.,
2015)] has been gained using ssNMR or cryoEM (Fitzpatrick
and Saibil, 2019; Gallardo et al., 2020b; Guerrero-Ferreira et al.,
2020; Scheres et al., 2020). These techniques, however, cannot
provide atomic resolution information about the structure of
the flexible regions which can comprise the large majority
of the protein sequence in some amyloid states (Figure 3;
Gallardo et al., 2020b). Nevertheless, some studies have shown
the importance of the amyloid “fuzzy coat” for interactions
with other amyloid precursors, cellular membranes, RNA and
chaperones (Figures 4, 5). Assays with protease-treated fibrils,
where the “fuzzy coat” is shaved off, would allow a better
understanding of which part of the fibril is involved in
the binding process and how the cellular consequences of
fibril formation depend on the dynamically disordered regions
displayed on the cross-β amyloid fold.
Fibril polymorphism has been shown to be responsible for
the development of different diseases caused by the same
protein [e.g., αSyn causing Parkinson’s disease or Multiple
System Atrophy or Dementia with Lewy Bodies (Shahnawaz
et al., 2020) or Tau causing Alzheimer’s disease, Pick’s disease,
chronic traumatic encephalitis, and corticobasal degeneration
(Fitzpatrick et al., 2017; Falcon et al., 2018; Scheres et al.,
2020)]. Polymorphs, so far, have been defined by a fibril
possessing a different core: but the flanking regions to the core
could also be different in fibrils with the same (or similar)
core structures. This adds a further, currently unexplored,
dimension to amyloid polymorphism and its consequences
for disease, since the dynamically disordered regions could
have different interactions with cellular components (Wegmann
et al., 2013). A more detailed analysis of the extent of
conformational fluctuation of these amyloid flanking regions,
for instance using EPR, cross-linking, or other techniques able
to tackle dynamic heterogeneity, in the future might reveal
“polymorphism” in the “fuzzy coat” and how this is related to the
development of disease.
It should not be forgotten that flanking regions can
have very different lengths. In the case of Aβ40/42, (nearly)
the whole protein forms the fibril core (Figure 3C) (Lu
et al., 2013; Gremer et al., 2017), whilst in other proteins,
e.g., Orb2, flanking regions >500 residues in length are
observed (Figure 3F; Hervas et al., 2020). Tompa (2009)
hypothesized that the longer the dynamically disordered region,
the more likely it can interact with other molecules by a
“fly fishing mechanism.” This might explain why functional
amyloid fibrils such as Orb2 have long flanking regions
able to interact with other proteins, RNA or surfaces, whilst
pathological amyloid fibrils, the sequences of which have
not evolved for functional reasons, may present shorter
flanking regions.
CONCLUSION
In summary, this review highlights the crucial role of regions
that flank the APRs in amyloidogenic protein sequences and the
dynamic regions that flank the amyloid fibril core for function,
fibril formation and cellular dysfunction for a few example
proteins. While beautiful fibril structures are now emerging
from cryoEM and ssNMR studies, the often poorly visible, but
functionally important flanking regions must not be forgotten.
Focusing more on these regions with a broad range of biophysical
and cellular techniques might help to gain a better understanding
of the molecular mechanism of fibril formation and to identify
new targets for drug development that do not involve the ordered
amyloid core and the aggregation hotspots.
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